Literature DB >> 3128367

Infective endocarditis complicating tricuspid valve disease in the carcinoid syndrome.

D G Menzies1, I W Campbell, I R Starkey.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3128367      PMCID： PMC2545299          DOI： 10.1136/bmj.296.6623.682

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  Malignant carcinoid of the small intestine with metastases to the liver, valvular disease of the right side of the heart (pulmonary stenosis and tricuspid regurgitation without septal defects), peripheral vasomotor symptoms, bronchoconstriction, and an unusual type of cyanosis; a clinical and pathologic syndrome.

Authors:  A THORSON; G BIORCK; G BJORKMAN; J WALDENSTROM
Journal:  Am Heart J       Date:  1954-06       Impact factor: 4.749

2.  The carcinoid endocardial plaque; an ultrastructural study.

Authors:  V J Ferrans; W C Roberts
Journal:  Hum Pathol       Date:  1976-07       Impact factor: 3.466

3.  Tricuspid valve replacement in carcinoid syndrome due to ovarian primary.

Authors:  M J Sworn; G P Edlin; D A McGill; J S Mousley; J L Monro
Journal:  Br Med J       Date:  1980-01-12

4.  Cross sectional echocardiographic feature in carcinoid heart disease. A mechanism for tricuspid regurgitation in this syndrome.

Authors:  M K Davies; P J Lowry; W A Littler
Journal:  Br Heart J       Date:  1984-03

5.  THE CARDIAC DISEASE ASSOCIATED WITH THE CARCINOID SYNDROME (CARCINOID HEART DISEASE).

Authors:  W C ROBERTS; A SJOERDSMA
Journal:  Am J Med       Date:  1964-01       Impact factor: 4.965
  5 in total
  2 in total

1.  Carcinoid heart disease with severe hypoxia due to interatrial shunt through patent foramen ovale.

Authors:  L R Boglioli; J Gardiner; G Gerstenblith; M L Taff; D E Cameron
Journal:  Tex Heart Inst J       Date:  1997

Review 2.  Carcinoid syndrome and serotonin: therapeutic effects of ketanserin.

Authors:  J I Robertson
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.